We are pleased to announce that the following patent application related to our Neuron DDS technology has been granted.
Title of Invention: Targeting Agent
Application Number: Japanese Patent Application No. 2024-517316
Patent Holder: Jiksak Bioengineering, Inc.
Overview: This patent relates to a technology for delivering substances to cells in central nervous system using antibodies that target neuronal synapses located in the periphery. This technology enables selective delivery to neurons, which was previously difficult to achieve, and is expected to find applications in the analysis of neural function and in therapeutic treatments.
We believe this patent grant will further strengthen the intellectual property foundation that supports our research and development activities and business advancement.